Table 1.
All patients (N=21) | |
---|---|
Characteristic | No. (%) |
Age, years | 49 ± 21 |
BMI, kg/m2 | 39.5 (30.3-62.4) |
Ethnicity | |
Non-Hispanic | 17 (81) |
Hispanic | 4 (19.1) |
Race | |
African American | 4 (19.1) |
Caucasian | 13 (61.9) |
Unknown | 4 (19.1) |
DM | 8 (38.1) |
History of DVT/PE | 1 (4.8) |
Hypertension | 7 (33.3) |
Immunocompromised | 1 (4.8) |
PVD | 0 (0) |
Smoking status | |
Never | 15 (71.4) |
Current | 7 (33.3) |
Former | 1 (4.8) |
BRCA | 4 (9.5) |
Neoadjuvant radiation | 2 (9.5) |
Bra size | |
B | 2 (9.5) |
D | 6 (28.6) |
DD | 6 (28.6) |
DDD | 5 (23.8) |
G | 1 (4.8) |
Implant size | |
800 mL | 34 (82.9) |
750 mL | 4 (9.5) |
700 mL | 4 (9.5) |
DM, diabetes; PVD, peripheral vascular disease; DVT, deep venous thrombus; PE, pulmonary embolus.